United States researchers 6th released the results of a new research shows that obesity can affect the hormone of menopause in women increase their risk of developing ovarian cancer risk. The study results will be published in the February 15 issue of the United States on the journal cancer.
is one of the most lethal Gynecologic Cancer ovarian cancer, 5-year survival rate is below 40%.
previous research has shown that, related to obesity and the incidence of certain cancers, but about the relationship between obesity and risk of ovarian cancer are inconclusive.
according to United States Science Foundation hosted the 6th EurekAlert website, to study the relationship between the two, United States maikeer·laiciman and others at the National Cancer Institute to 94,525 men, aged 50 to 71 of the United States women’s track of a 7-year study. During this period, a total of 303 people suffering from ovarian cancer.
researchers found after analysis, not using hormone replacement therapy in women after the menopause, obesity risk of developing ovarian cancer than normal high 80%, and hormone replacement therapy in postmenopausal women, ovarian cancer the risk of obesity and weight gain does not differ significantly from the normal.
laiciman believe that obese of the postmenopausal women will continue to produce estrogen in the body, further promotion of ovarian cells, thereby increasing the risk of developing ovarian cancer risk, means supplemental hormones and hormone replacement therapy in treating . hormone imbalance causes illness treatment, it helps women menopause the body maintain normal hormone levels.